Medicalization

BeautyHealth 2023 Skintuition Report: The Skin Health Trends and Data Shaping the Year

Retrieved on: 
Tuesday, December 12, 2023
Cosmetics, Retail, Journal of Cosmetic Dermatology, Human, SKIN, Behavior, Treatment, Journal of Dermatological Treatment, Communication, Journal, Hydradermabrasion, Skin, Radical, Intelligence, Medicalization, Knowledge, Beauty, Face, Pharmaceutical industry, Beauty salon, Peptide, MD

This collective intelligence and proprietary data put BeautyHealth in a unique position to reflect on the trends that shaped 2023 and those that it believes will emerge in 2024.

Key Points: 
  • This collective intelligence and proprietary data put BeautyHealth in a unique position to reflect on the trends that shaped 2023 and those that it believes will emerge in 2024.
  • “We are thrilled to unveil our first-ever Skintuition Report and share insights culled from our connected platform and global community of skin health providers.
  • In addition to consumer and provider behavior data, the 2023 BeautyHealth Skintuition Report catalogues long-standing and more recent peer-reviewed clinical studies, which analyze the efficacy of the Hydrafacial treatment.
  • Data insights in the Skintuition Report are generated from BeautyHealth sales data, Hydrafacial Syndeo device data, published clinical studies, provider testimonials, and third-party measurement tools.

Annals of Family Medicine: Researchers Describe Clinical Experiences of Transgender People, Recommend Strategies to Reduce Negative Health Consequences

Retrieved on: 
Monday, September 18, 2023
Medicalization, Annals of Family Medicine, Society, University, College, Physician, Curriculum, Empowerment, Yale Cancer Center, American Academy, North American Primary Care Research Group, Research, Multimedia, American Board of Family Medicine, American Board of Commissioners for Foreign Missions, Stigma, Family medicine, Patient, University of Rochester Medical Center, College of Family Physicians of Canada, American Academy of Family Physicians, Assault, Teacher, Safety, Nursing, Pharmaceutical industry, Annals

A new paper published in the September/October 2023 issue of Annals of Family Medicine describes the clinical experiences of transgender people.

Key Points: 
  • A new paper published in the September/October 2023 issue of Annals of Family Medicine describes the clinical experiences of transgender people.
  • Study authors also present short-term and long-term strategies towards reducing oppression and its health consequences among this patient population.
  • "Understanding the experiences of transgender people when their gender identities are known to clinicians and the reasons transgender people may share, modify, or withhold information could yield important clinical insights," the authors write.
  • Annals of Family Medicine is a peer-reviewed, indexed research journal that provides a cross-disciplinary forum for new, evidence-based information affecting the primary care disciplines.

Latest Canadian Pet Population Figures Released

Retrieved on: 
Thursday, September 22, 2022
Health, Agriculture, COVID-19, Senior, Life, Veterinarian, Mental health, Ownership, Cat, Quality of life, Medicalization, Research, GLOBE, PETS, Animal, Dog, Pet, Veterinary medicine, Ipsos

Toronto, Ontario, Sept. 22, 2022 (GLOBE NEWSWIRE) -- The Canadian Animal Health Institute (CAHI) is pleased to share the results of its 2022 Pet Population Survey.

Key Points: 
  • Toronto, Ontario, Sept. 22, 2022 (GLOBE NEWSWIRE) -- The Canadian Animal Health Institute (CAHI) is pleased to share the results of its 2022 Pet Population Survey.
  • These figures are the result of a nation-wide survey of 4,000 pet-owning households, conducted by Kynetec (formerly Ipsos), and continue historical tracking of pet population numbers on behalf of the CAHI since 2004.
  • This years pet population results incorporate both improvements made by Kynetec to the surveys methodology and additional market intelligence to best reflect the status of pet ownership in Canada.
  • From 2020-2022, the Canadian dog and cat populations continued to grow, increasing from 7.7 million to 7.9 million for dogs, and from 8.1 million to 8.5 million for cats.

Optimi Health Enters Into International Collaborative Research and Supply Agreement With Promises Innovative Recovery Center

Retrieved on: 
Tuesday, August 30, 2022
Partnership, MDMA, CSE, Research, Psilocybin, Addiction, United States Public Health Service, SAP, Precision medicine, Center of excellence, Health Canada, BC, GLOBE, Center, Leadership, Company, Therapy, Justin, PIR, Cannabis, FRA, Medicalization, Medical tourism, Substance abuse, Industry, FOR, Private sector, Medicine, Pharmaceutical industry, Medical device

Further, PIR is a globally minded medical, research, and educational center focusing on preventative healthcare, precision medicine, and innovative treatments, including psychedelic-assisted psychotherapy and plant-based therapeutics.

Key Points: 
  • Further, PIR is a globally minded medical, research, and educational center focusing on preventative healthcare, precision medicine, and innovative treatments, including psychedelic-assisted psychotherapy and plant-based therapeutics.
  • The Company, along with licensed cannabis producer Castle Rock Farms Inc ., a Princeton, British Columbia-based subsidiary of BC Green Pharmaceuticals Inc .
  • The need for a safe, consistent supply of psilocybin for scientific research and better health outcomes are not limited to Canada, said Optimi Health CEO Bill Ciprick.
  • Promises Innovative Recovery Co-Founder, Gary Roberts, is meeting with Costa Rican officials and interested stakeholders this week to discuss the licensed framework.

New Fenway Health Study Examines The "Social Contagion" Hypothesis of Transgender and Gender Diverse Identities

Retrieved on: 
Wednesday, August 3, 2022
Health policy, Public policy, University of California, Irvine Medical Center, Medicalization, Assistant, Publication, National, Male, ROGD, Bullying, University, Agency, Sex ratio, Psychiatry, American Academy of Child and Adolescent Psychiatry, Suicide, TDG, Policy, Research, Massachusetts General Hospital Psychiatry Academy, Sex, Gender dysphoria, Parent, TGD, Female, Economist, Toy, Birth control, Pediatrics, Medicaid, Science

BOSTON, Aug. 3, 2022 /PRNewswire-PRWeb/ -- A study published today in Pediatrics, using a large national dataset of adolescents in the U.S., provided evidence against the notion that adolescents in the U.S. come to identify as transgender due to "social contagion."

Key Points: 
  • The study also found that the percentage of teens openly identifying as transgender or gender diverse (TGD) did not increase between 2017 and 2019.
  • The study adds important new knowledge to the evolving field of transgender health care and ongoing public debate of legislative measures regulating access to gender-affirming health care.
  • Yet the 2018 study popularizing the ROGD hypothesis was based on surveys completed by 256 parents with no input from TGD youth.
  • "The damaging effects of these unfounded hypotheses in further stigmatizing transgender and gender diverse youth cannot be understated.

Canonic Announces Professor Itamar Grotto Joining its Board of Directors

Retrieved on: 
Wednesday, February 16, 2022
NASDAQ, Medicalization, Patient, TASE, CEO, World, Company, AG, Board of directors, Therapy, Federal Executive Boards, Technology, Risk, Biology, Board, Ministry, Agriculture, Castor oil, Associate, Genetics, World Health Organization, Computational biology, Artificial intelligence, Computation, CPB, Medicinal plants, Health, Cannabis, Canonical

REHOVOT, Israel, Feb. 16, 2022 /PRNewswire/ -- Canonic Ltd., focused on the development of medical-grade cannabis products and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today that Professor Itamar Grotto will be joining its Board of Directors.

Key Points: 
  • REHOVOT, Israel, Feb. 16, 2022 /PRNewswire/ -- Canonic Ltd., focused on the development of medical-grade cannabis products and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today that Professor Itamar Grotto will be joining its Board of Directors.
  • The addition of Professor Grotto to Canonic's board is expected to support key objectives of the company, including the development and commercialization of medical cannabis products targeting specific indications under Canonic's Precise program [1].
  • Professor Itamar Grotto stated, "After many years of professional and regulatory work with the medical cannabis industry in both Israel and worldwide, I am very pleased to join Canonic, a company that has the potential to bring better products to cannabis patients.
  • Arnon Heyman, CEO of Canonic added, "On behalf of the entire team, I welcome Professor Itamar Grotto to Canonic.

Chacruna Institute releases its second workshop on implicit bias for Psychedelic Therapists, Researchers, and Educators

Retrieved on: 
Thursday, December 2, 2021
Research, Racism, MAPS, Psychedelic drug, Awareness, Executive, Equity, Competency management system, SAN, Education, Medicalization, Risk, BIPOC, Nicole, Organization, Stereotype, Social media, Impact, Social justice, Comment, Outline, Public relations

SAN FRANCISCO, Dec. 2, 2021 /PRNewswire-PRWeb/ --On Mon, December 13, 2021, the Chacruna Institute for Psychedelic Plant Medicines will be hosting an interactive workshop " Implicit Bias, Therapy, and Psychedelics: Reducing the Impact of Bias on Therapy, Education, Training, and Research ."

Key Points: 
  • SAN FRANCISCO, Dec. 2, 2021 /PRNewswire-PRWeb/ --On Mon, December 13, 2021, the Chacruna Institute for Psychedelic Plant Medicines will be hosting an interactive workshop " Implicit Bias, Therapy, and Psychedelics: Reducing the Impact of Bias on Therapy, Education, Training, and Research ."
  • Participants of this workshop will learn about implicit bias, what it is, why it happens, and how it impacts our interactions in personal and professional contexts.
  • "Knowing how to deal with bias will make you a better therapist, mentor, and scholar.
  • With this workshop, the Chacruna Institute and its Racial Equity and Access Committee continues to set the example for how psychedelic organizations can integrate solidarity, equity, and social justice into their professional and personal work.

Universal Ibogaine Announces Chief Clinics Officer Dr Ian Rabb

Retrieved on: 
Thursday, November 4, 2021
Destiny, Aurora, Gimli, Diamond, Sola, Safety, Cocaine, Housing, THE, Interventionism, TSX, Jews, BC Children's Hospital Foundation, Medicalization, Program, Acquisition, UI, Community advisory board, Research, Opioid use disorder, Universal, Health Canada, Kelburn, AB, Oxycodone, Scotiabank, Education, Heroin, Science, LDS Family Services, Exercise, Leadership, News, Hotel manager, Clinical trial, Fentanyl, Time, Cuban medical internationalism, Child and family services, Plant, Business, Employment, THIS, Drug, Pharmaceutical industry, Medical device

CALGARY, AB, Nov. 4, 2021 /CNW/ - Universal Ibogaine Inc. (TSXV: IBO) ("Universal Ibogaine", "UI" or the "Company"), a life sciences company with a mission to research and deliver medicalized ibogaine-centered addiction care, is pleased to announce an expansion of its Executive Team and welcomes addiction treatment and clinic operations veteran Dr Ian Rabb as Chief Clinics Officer effective November 15, 2021.

Key Points: 
  • CALGARY, AB, Nov. 4, 2021 /CNW/ - Universal Ibogaine Inc. (TSXV: IBO) ("Universal Ibogaine", "UI" or the "Company"), a life sciences company with a mission to research and deliver medicalized ibogaine-centered addiction care, is pleased to announce an expansion of its Executive Team and welcomes addiction treatment and clinic operations veteran Dr Ian Rabb as Chief Clinics Officer effective November 15, 2021.
  • Dr Ian Rabb is one of the most recognized and respected leaders in Addiction Treatment in Canada today.
  • Dr. Ian Rabb is a certified Interventionist and addictions specialist who has helped thousands of people overcome addiction.
  • Dr Ian Rabb will take the helm at the Universal Ibogaines recently acquired addiction treatment facility located outside of Winnipeg, Manitoba.

Emotional Intelligence Ventures Reg A Raise at $20M, Company Pursues Psylocibin Transdermal Delivery Research, Plans Nutraceutical Mushroom Supplements Launch

Retrieved on: 
Tuesday, October 19, 2021
Alternative Medicine, Health, Research, Pharmaceutical, Science, Biotechnology, Immune system, Emotional Intelligence, Seattle City Council, Weight loss, Goal, EI, Betterment, Medicalization, Airbnb, Fungus, Council, Research, Vidyard, Mental health, Time, CEO, Forward-looking statement, Forbes, Sleep, Smart drug, Cognition, Wefunder, Company

Ultimately, they are looking to raise a maximum of $49,999,999, and believe this is a completely doable goal.

Key Points: 
  • Ultimately, they are looking to raise a maximum of $49,999,999, and believe this is a completely doable goal.
  • The net proceeds of the offering will be used to accelerate the development and distribution of Eis medicinal and functional mushroom product lines.
  • David Nikzad, founder and CEO of Ei.Ventures notes, We are so committed to the nonaccredited investor, that we are pursuing a Regulation A offering.
  • As part of Eis dual track approach, they are planning to launch their line of functional mushroom MANA nutraceuticals in early 2022.

Chacruna Institute and Mexican grassroots organizations join forces in a Psilocybin Symposium to discuss the medicalization and commodification of psilocybin in the US

Retrieved on: 
Monday, September 13, 2021
Psilocybin, Knowledge, PTSD, International Symposium on Endovascular Therapy, North–South divide in the World, Culture, Depression, Doctor of Philosophy, Institute, Anxiety, Medicalization, Head, Social, Addiction, Psychedelic drug, Hope, Research, MEXICO, Pharmaceutical industry

However, despite this burgeoning interest, the challenges brought about by psilocybin's growing globalization, commercialization, and medicalization is rarely addressed.

Key Points: 
  • However, despite this burgeoning interest, the challenges brought about by psilocybin's growing globalization, commercialization, and medicalization is rarely addressed.
  • Meanwhile, the realities of the Indigenous cultures that have long included sacred mushrooms in their ancestral healing practices remain almost entirely invisible.
  • In response to these challenges, the Chacruna Institute, along with the Mexican non-profit organizations Va Synapsis, The Mexican Psilocybin Society, and MindSurf, have joined forces to hold The International Symposium on Psilocybin: Therapeutic Potentials, Culture, and Decolonization on September 2021, 2021.
  • International Psilocybin Symposium: Therapeutic Potentials, Culture and Decolonization will take place on September 20th-21st 2021, 8:30 to 17:30 PST.